Highlights from a satellite symposium held on Friday, May 18, 2007 in Anaheim, California.

Release date: September 2007
Expiration date: September 30, 2008
Estimated time to complete activity: 1.5 hours

Sponsored by

Support for this activity has been provided through an educational grant from

Hardware/Software Requirements
 - JavaScript-enabled browser
 - Active Internet connection
 - Adobe Acrobat Reader
 - Adobe Flash Player Plugin v.8.0+

  

Activity Overview
The prevalence of lower urinary tract symptoms (LUTS) increases in men over the age of 40. Urinary symptoms of both bladder and prostate origin are among the hallmarks of LUTS. This program discusses in detail the bladder- and prostate-related etiology of LUTS. It also discusses the use of 5-α-reductase inhibitors, phosphodiesterase inhibitors, and antimuscarinic agents. The remaining focus of the activity is on individualizing treatment of LUTS.

Target Audience
This activity has been designed to meet the educational needs of urologists and other health care professionals who treat male patients with LUTS.

Learning Objectives
Upon completion of this activity, participants should be better able to:

• Explain the prostate and bladder origin of male LUTS and differentiate symptoms suggestive of each condition
• Identify overlapping issues associated with male LUTS and sexual dysfunction
• Formulate an appropriate management strategy for male patients with LUTS
• Determine which male LUTS patients are candidates for antimuscarinic treatment

Program Faculty
Kevin T. McVary, MD, FACS View biography
Professor of Urology
Northwestern University
Feinberg School of Medicine
Director, Center for Sexual Health
Northwestern Memorial Hospital
Chicago, Illinois

Claus G. Roehrborn, MD View biography
Professor and Chairman
Department of Urology
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas

Accreditation Statement
Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
Curatio CME Institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physicians should not claim credit for this activity if credit was previously claimed for the symposium on which this Internet activity is based.

Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period September 2007 to September 30, 2008, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form, including the certificate information section.

To obtain a certificate, you must receive a score of 70% or better on the posttest. The posttest can be accessed at the end of the activity. Please e-mail any questions to cmeinfo@curatiocme.com.

Medium
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.

Disclosure
In accordance with the ACCME’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:

Curatio CME Institute
Shari J. Dermer, PhD, Medical Director, has disclosed no relevant financial relationships.
Thomas Finnegan, PhD, Medical Writer, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships.

Disclaimer
The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.

Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute and Pfizer, Inc. do not recommend the use of any agent outside the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute or Pfizer, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy Policy
Curatio CME Institute collects the information provided by the user. The information is used to notify users about upcoming programs and educational information that may be of interest. The information is not shared with others for commercial purposes, unless prior permission has been granted by the user.

Curatio CME Institute may collect standard Web traffic data such as the time and date of visit. Curatio CME Institute uses this information to administer its Web site. Browsing activity is recorded to form aggregate and anonymous demographic information, which is used as described above. Curatio CME Institute does not sell or offer to sell any user data, including registration and billing information, to any third parties for commercial purposes. Curatio CME Institute does, when required, provide the minimum subset of information to third parties that are responsible for accreditation and issuance of certification of CME/CE tests submitted. By participating in the Web-based activity, you agree that Curatio CME Institute has full permission to provide this minimum subset of information to the third parties as required by law.